MedWatch

Novo Holdings plans to enter China

Following three investments via the newly-established Singapore office, Novo Holdings is poised to expand its Asian venture to China, where it hopes to open an office before the end of the year.

Novo Holdings Senior Partner, Head of Novo Holdings Asia Amit Kakar | Photo: Novo Holdings

Novo Holdings' newly-opened Singapore office has been busy this spring.

Over the course of one month, the Danish investment company has posted funds in three companies in Singapore and Indonesia, and the kick-off of Novo Holdings' Asian venture has been so successful that the firm plans to expand, and has set its sights on China.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Pfizer upgrades guidance for sales of covid-19 vaccine

The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.

Further reading

Related articles

Trial banner

Latest news

See all jobs